AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three months ended

AURORA CANNABIS INC.

Condensed Consolidated Interim Financial Statements

For the three months ended June 30, 2023 and

(in Canadian Dollars)

Nature of Operations (Note 1)

Commitments and Contingencies (Note 16)

Subsequent Events (Note 21)

The accompanying notes are an integral part of these Condensed Consolidated

Interim Financial Statements.

The accompanying notes are an integral part of these Condensed

Consolidated Interim Financial Statements.

(1) Comparative information has been re-presented

due to discontinued operations see Note 6(b).

The accompanying notes are an integral part of these Condensed Consolidated

Interim Financial Statements.

(1) Comparative information has been re-presented

due to discontinued operations see Note 6(b).

The accompanying notes are an integral part

of these Condensed Consolidated Interim Financial Statements.

The accompanying notes are an integral part of these Condensed Consolidated

Interim Financial Statements.

Supplemental cash flow information (Note 15)

The accompanying notes are an integral part of these Condensed

Consolidated Interim Financial Statements.

(1) Comparative information has been re-presented

due to discontinued operations see Note 6(b).

Aurora Cannabis Inc. (the "Company"

or "Aurora") was incorporated under the Business Corporations Act (British Columbia) on December 21, 2006 as Milk

Capital Corp. Effective October 2, 2014, the Company changed its name to Aurora Cannabis Inc. The Company's shares are listed

on the Nasdaq Global Select Market ("Nasdaq") and the Toronto Stock Exchange ("TSX") under the trading symbol

"ACB", and on the Frankfurt Stock Exchange ("FSE") under the trading symbol "21P1".

The Company's head office and principal address

is 3498 - 63 Avenue, Leduc, Alberta, Canada, T9E 0G8. The Company's registered and records office address is Suite 1700, 666 Burrard

Street, Vancouver, British Columbia, Canada, V6C 2X8.

The Company's principal strategic business

lines are focused on the production, distribution and sale of cannabis related products in Canada and internationally. Aurora currently

conducts the following key business activities in the jurisdictions listed below:

Accounting Policies and Judgments

of Presentation and Measurement

The condensed interim consolidated interim financial

statements of the Company have been prepared in accordance with International Financial Reporting Standards ("IFRS") and International

Accounting Standards 34, Interim Financial Reporting ("IAS 34") as issued by the International Accounting Standards

Board ("IASB"), and interpretations of the IFRS Interpretations Committee ("IFRIC"). Unless otherwise noted, all

amounts are presented in thousands of Canadian dollars, except share and per share data.

The condensed consolidated interim financial statements

are presented in Canadian dollars and are prepared in accordance with the same accounting policies, critical estimates and methods described

in the Company's annual consolidated financial statements, except for the adoption of new accounting policies (Note 2(d)). Given

that certain information and footnote disclosures, which are included in the annual audited consolidated financial statements, have been

condensed or excluded in accordance with IAS 34, these condensed consolidated interim financial statements should be read in conjunction

with our annual audited consolidated financial statements as at and for the year ended March 31, 2023, including the accompanying notes

The condensed interim consolidated financial statements

include the financial results of the Company and its subsidiaries. Subsidiaries include entities which are wholly-owned as well as entities

over which Aurora has the authority or ability to exert power over the investee's financial and/or operating decisions (i.e. control),

which in turn may affect the Company's exposure or rights to the variable returns from the investee. The consolidated interim financial

statements include the operating results of acquired or disposed entities from the date control is obtained or the date control is lost,

respectively. All intercompany balances and transactions are eliminated upon consolidation.

The Company's principal subsidiaries

during the three months ended June 30, 2023 are as follows:

All shareholdings are of ordinary shares or other

equity. Other subsidiaries, while included in the consolidated financial statements, are not material and have not been reflected in the

(c) Discontinued operations

The Company reports financial results for discontinued

operations separately from continuing operations to distinguish the financial impact of disposal transactions from ongoing operations.

Discontinued operations reporting occurs when the disposal of a component or a group of components of the Company represents a strategic

shift that will have an impact on the Company's operations and financial results, and where the operations and cash flows can be

clearly distinguished, operationally and for financial reporting purposes, from the rest of the Company.

The results of discontinued operations are excluded

from both continuing operations and business segment information in the condensed consolidated interim financial statements and the notes

to the consolidated financial statements, unless otherwise noted, and are presented net of tax in the consolidated statements of loss

and comprehensive income (loss) for the current and comparative periods. Refer to Note 6(b) Discontinued Operations.

1: Classification of Liabilities as Current or Non-current

The amendment clarifies the requirements relating

to determining if a liability should be presented as current or non-current in the statement of financial position. Under the new requirement,

the assessment of whether a liability is presented as current or non-current is based on the contractual arrangements in place as at the

reporting date and does not impact the amount or timing of recognition. The amendment applies retrospectively for annual reporting periods

beginning on or after January 1, 2023. There were no changes to the Company's current period or comparative period upon adoption.

Amendments to IAS 12: Income Taxes

The amendment clarifies how companies account for

deferred tax on transactions such as leases and decommissioning obligations. The amendments are effective for annual periods beginning

on or after January 1, 2023. There was no material impact as a result of adopting these amendments.

Amendments to IAS 12: Deferred Tax related to

Assets and Liabilities arising from a Single Transaction

The amendment narrowed the scope of certain recognition